RegenLab Files for IPO

By Katherine HamiltonRegenLab filed for an initial public offering.The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA.RegenLab was founded in Switzerland and is now U.S.-based. It operates three manufacturing sites and dedicated research and development and clin…